ReviewInternational journal of molecular sciences2017

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.

Toshiaki Nakaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.